A Case of Neuroendocrine Carcinoma of the Anal Canal

A 62-year-old woman presented to our clinic because of anal pain was found having a palpable anal tumor by digital examination of the rectum. Colonoscopy revealed a ridging lesion with ulcer at the anal canal. A biopsy offered a diagnosis of neuroendocrine carcinoma. Apart from the anal canal tumor,...

Full description

Saved in:
Bibliographic Details
Published inNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) Vol. 79; no. 10; pp. 2139 - 2144
Main Authors KOBAYASHI, Hiroyuki, KUROKAWA, Tsuyoshi, SHIMIZU, Minoru, NAKAYAMA, Hiroshi, HISHIDA, Mitsuhiro, TORII, Koji, HARADA, Tomoko
Format Journal Article
LanguageJapanese
Published Japan Surgical Association 2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 62-year-old woman presented to our clinic because of anal pain was found having a palpable anal tumor by digital examination of the rectum. Colonoscopy revealed a ridging lesion with ulcer at the anal canal. A biopsy offered a diagnosis of neuroendocrine carcinoma. Apart from the anal canal tumor, an extramural tumor of the rectum and a presacral tumor were revealed on a CT scan. PET-CT scan showed abnormal uptakes of FDG in all the three tumors. Lymph node metastases of anal canal carcinoma were diagnosed, and abdominoperineal resection + D3 lymph node dissection was performed. The resected specimen included the anal canal tumor with the size of 25 × 25 mm in diameter. Histopathologically the tumor was substantially composed of proliferation of large oval-shaped cells with a large N/C ratio and the progression was rated as Stage IIIb. On immunohistochemistry, the anal canal tumor was strongly positive for synaptophysin and positive for chromogranin A, with the Ki-67 positive rate of 60%. Furthermore, we also confirmed well-differentiated adenocarcinoma and villous adenoma in the oral margin of the tumor. Neuroendocrine carcinoma arisen in the anal canal was thus diagnosed. We performed mFOLFOX (6) as adjuvant chemotherapy.
ISSN:1345-2843
1882-5133
DOI:10.3919/jjsa.79.2139